Merck & Co. Inc. said on Monday it has applied for U.S. emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease.
source https://www.cbc.ca/news/world/coronavirus-covid19-canada-world-oct11-2021-1.6207161?cmp=rss
No comments:
Post a Comment